<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 15 (filtered medium)"><!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:Wingdings;
panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"Arial Black";
panose-1:2 11 10 4 2 1 2 2 2 4;}
@font-face
{font-family:Tahoma;
panose-1:2 11 6 4 3 5 4 4 2 4;}
@font-face
{font-family:inherit;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
h1
{mso-style-priority:9;
mso-style-link:"Heading 1 Char";
margin-top:3.75pt;
margin-right:0in;
margin-bottom:15.0pt;
margin-left:0in;
line-height:27.0pt;
font-size:27.0pt;
font-family:inherit;
font-weight:bold;}
h5
{mso-style-priority:9;
mso-style-link:"Heading 5 Char";
margin-top:7.5pt;
margin-right:0in;
margin-bottom:7.5pt;
margin-left:0in;
font-size:11.5pt;
font-family:inherit;
font-weight:bold;}
h6
{mso-style-priority:9;
mso-style-link:"Heading 6 Char";
margin-top:7.5pt;
margin-right:0in;
margin-bottom:7.5pt;
margin-left:0in;
font-size:10.0pt;
font-family:inherit;
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:#954F72;
text-decoration:underline;}
span.Heading1Char
{mso-style-name:"Heading 1 Char";
mso-style-priority:9;
mso-style-link:"Heading 1";
font-family:inherit;
font-weight:bold;}
span.Heading5Char
{mso-style-name:"Heading 5 Char";
mso-style-priority:9;
mso-style-link:"Heading 5";
font-family:inherit;
font-weight:bold;}
span.Heading6Char
{mso-style-name:"Heading 6 Char";
mso-style-priority:9;
mso-style-link:"Heading 6";
font-family:inherit;
font-weight:bold;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle21
{mso-style-type:personal;
font-family:"Calibri",sans-serif;}
span.z-TopofFormChar
{mso-style-name:"z-Top of Form Char";
mso-style-priority:99;
mso-style-link:"z-Top of Form";
font-family:"Arial",sans-serif;
display:none;}
span.z-BottomofFormChar
{mso-style-name:"z-Bottom of Form Char";
mso-style-priority:99;
mso-style-link:"z-Bottom of Form";
font-family:"Arial",sans-serif;
display:none;}
span.dropdown-topic
{mso-style-name:dropdown-topic;}
span.EmailStyle29
{mso-style-type:personal-reply;
font-family:"Arial Black",sans-serif;
font-weight:bold;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:84809784;
mso-list-template-ids:-1273303520;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1
{mso-list-id:1303071809;
mso-list-template-ids:1401873638;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:o;
mso-level-tab-stop:1.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:"Courier New";
mso-bidi-font-family:"Times New Roman";}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:1.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:2.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:3.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.0in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:;
mso-level-tab-stop:4.5in;
mso-level-number-position:left;
text-indent:-.25in;
mso-ansi-font-size:10.0pt;
font-family:Wingdings;}
ol
{margin-bottom:0in;}
ul
{margin-bottom:0in;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-US link="#0563C1" vlink="#954F72"><div class=WordSection1><p class=MsoNormal><b><span style='font-size:20.0pt;font-family:"Arial Black",sans-serif'><o:p> </o:p></span></b></p><p class=MsoNormal><b><span style='font-size:20.0pt;font-family:"Arial Black",sans-serif'><o:p> </o:p></span></b></p><div><div style='border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in 0in 0in'><p class=MsoNormal><b>From:</b> Lester Cameron <underdogmj@comcast.net> <br><b>Sent:</b> Friday, November 9, 2018 2:14 PM<br><b>To:</b> ange.mperone@optimum.net <angela.mperone@optimum.net><br><b>Subject:</b> from less read it is good info Fw: Blind Vine with a share from our reader, Alfred Fredel about new glucose monitoring<o:p></o:p></p></div></div><p class=MsoNormal><o:p> </o:p></p><div><div><div><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:black'>ange do not answer this email to me <o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:black'>and any email you may sent to me will be automatically will return to you <o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:black'>this is some thing u should look in to because you do not watch your sugar close enough that is y u have so manny hi’s and low’s <o:p></o:p></span></p></div><div><p class=MsoNormal><span style='font-size:12.0pt;font-family:"Arial",sans-serif;color:black'> <o:p></o:p></span></p></div><div><div><div><p class=MsoNormal><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'> <o:p></o:p></span></p></div><div><div><p class=MsoNormal style='background:whitesmoke'><b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'>From:</span></b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'> <a href="mailto:dea23@optonline.net" title="dea23@optonline.net">Debbie Azzarone</a> <o:p></o:p></span></p></div><div><p class=MsoNormal style='background:whitesmoke'><b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'>Sent:</span></b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'> Friday, November 09, 2018 1:19 PM<o:p></o:p></span></p></div><div><p class=MsoNormal style='background:whitesmoke'><b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'>To:</span></b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'> <a href="mailto:dea23@optonline.net" title="dea23@optonline.net">Debbie Azzarone</a> <o:p></o:p></span></p></div><div><p class=MsoNormal style='background:whitesmoke'><b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'>Subject:</span></b><span style='font-size:10.0pt;font-family:"Tahoma",sans-serif;color:black'> Blind Vine with a share from our reader, Alfred Fredel about new glucose monitoring<o:p></o:p></span></p></div></div></div><div><p class=MsoNormal><span style='font-size:12.0pt;color:black'> <o:p></o:p></span></p></div></div><div><p class=MsoNormal><span style='color:black'>Hello Viners,<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'> <o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>Here’s a share from Alfred Fredel that will interest diabetics.<o:p></o:p></span></p><p class=MsoNormal><span style='color:black'>This app, unlike others, I’m happy to see has text to speech capabilities.<o:p></o:p></span></p><div style='border:none;border-bottom:dotted windowtext 3.0pt;padding:0in 0in 1.0pt 0in'><p class=MsoNormal><span style='color:black'> <o:p></o:p></span></p></div><p style='background:white'><strong><span lang=EN style='font-size:12.0pt;font-family:"Arial",sans-serif;color:#333333'>Endocrinology</span></strong><span lang=EN style='font-size:12.0pt;font-family:"Arial",sans-serif;color:#333333'><o:p></o:p></span></p><div style='border:solid #CCCCCC 1.0pt;padding:4.0pt 0in 4.0pt 0in'><p class=MsoNormal style='mso-margin-top-alt:auto;margin-bottom:3.75pt;margin-left:15.0pt;text-indent:-.25in;line-height:13.5pt;mso-list:l0 level2 lfo2;background:white'><![if !supportLists]><span lang=EN style='font-size:10.0pt;font-family:"Courier New";color:#333333'><span style='mso-list:Ignore'>o<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'><a href="https://www.healio.com/endocrinology/diabetes">Diabetes</a><o:p></o:p></span></p></div><p class=MsoNormal style='margin-bottom:15.0pt;line-height:27.0pt;background:white'><b><span lang=EN style='font-size:27.0pt;font-family:inherit;color:#333333'>FDA approves mobile app for Freestyle Libre<o:p></o:p></span></b></p><p class=MsoNormal style='background:white'><span lang=EN style='font-size:8.5pt;font-family:inherit;color:#919191'>November 1, 2018<o:p></o:p></span></p><p class=MsoNormal style='line-height:13.5pt;background:white'><span style='color:black'><img border=0 width=19 height=6 style='width:.1979in;height:.0625in' id="_x0000_i1025" src="cid:image001.png@01D48FAE.C0634640" alt=Healio></span><span lang=EN style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#333333'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>The FDA approved a mobile app for use with the Freestyle Libre 10-day and 14-day glucose monitoring systems, allowing patients with diabetes to monitor glucose readings on their compatible iPhone devices, Abbott announced in a press release.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>The FreeStyle LibreLink app enables users to hold their iPhone near their FreeStyle Libre or FreeStyle Libre 14-day sensor to instantly capture and view their real-time glucose levels, assess their 8-hour glucose history, and see a directional arrow indicating how their glucose is changing, according to the release. The FreeStyle LibreLink app also includes a series of in-app reports that visualize trends and patterns to help patients understand how well they are controlling their glucose.<o:p></o:p></span></p><div style='border:none;border-top:solid #444444 1.5pt;padding:4.0pt 0in 0in 0in'><p class=MsoNormal style='margin-bottom:3.75pt;background:white'><b><span lang=EN style='font-size:12.0pt;font-family:inherit;color:#333333'>See Also<o:p></o:p></span></b></p></div><p class=MsoNormal style='mso-margin-top-alt:auto;margin-bottom:3.75pt;margin-left:0in;text-indent:-.25in;line-height:13.5pt;mso-list:l1 level1 lfo4;background:white'><![if !supportLists]><span lang=EN style='font-size:10.0pt;font-family:Symbol;color:#333333'><span style='mso-list:Ignore'>·<span style='font:7.0pt "Times New Roman"'> </span></span></span><![endif]><span lang=EN style='font-size:10.0pt;font-family:"Arial",sans-serif;color:#333333'><a href="https://www.healio.com/endocrinology/diabetes/news/online/%7B3c13c116-ba4c-4296-a476-8d1abf796cd3%7D/fda-approves-14-day-freestyle-libre-cgm-sensor-for-diabetes"><span style='color:#0355C2'>FDA approves 14-day FreeStyle Libre CGM sensor for…</span></a><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>“We’re committed to liberating people from the many hassles of diabetes management through our life-changing technology and tools,” <b>Jared Watkin,</b> senior vice president of Diabetes Care at Abbott, said in the release. “The FreeStyle LibreLink app is a digital health tool that integrates glucose data directly on a compatible smartphone so all of the mobile apps that people use every day are in one convenient place. This is another step forward in making glucose monitoring seamlessly fit into a patient’s daily lifestyle — helping them live a fuller, healthier life.”<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>According to the press release, The FreeStyle LibreLink app has several new features as compared with the FreeStyle Libre and FreeStyle Libre 14-day readers, including a larger, high-resolution display, text-to-speech capabilities for glucose readings (when enabled), the ability to log smaller doses of insulin (0.1 U vs. 0.5 U), and support for 26 languages.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>FreeStyle LibreLink users also have the option to automatically share their glucose information with their health care professional and caregivers.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>FreeStyle LibreLink app will be free to download through the Apple App Store in the coming weeks, according to Abbott. Once available, patients will be able to pair the <a href="https://www.freestylelibre.us/?source=freestylelibre.com" target="_blank"><span style='color:#0355C2'>FreeStyle Libre</span></a> or FreeStyle Libre 14-day sensors with the app. The Android version of the app is currently under development.<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>As <a href="https://www.healio.com/endocrinology/diabetes/news/online/%7b3c13c116-ba4c-4296-a476-8d1abf796cd3%7d/fda-approves-14-day-freestyle-libre-cgm-sensor-for-diabetes" target="_blank"><i><span style='color:#0355C2'>Endocrine Today </span></i><span style='color:#0355C2'>previously reported</span></a>, the FDA in July approved the FreeStyle Libre flash glucose monitoring system, which allows patients with diabetes to wear the sensor up to 14 days with high accuracy. That approval made Abbott’s continuous glucose monitor the longest-lasting, self-applied personal glucose sensor available on the market, with improved accuracy and reduced warmup time. The FDA approved a 10-day version of the CGM system in <a href="https://www.healio.com/endocrinology/diabetes/news/online/%7b3c13c116-ba4c-4296-a476-8d1abf796cd3%7d/fda-approves-14-day-freestyle-libre-cgm-sensor-for-diabetes" target="_blank"><span style='color:#0355C2'>September 2017</span></a>, making it the first CGM system in the U.S. that did not require finger-stick calibration for adults with diabetes. <o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>The FreeStyle LibreLink app is compatible with near-field communication (NFC)-enabled phones on Apple’s iPhone 7 and later, running iOS 11 and later. – <i>by Regina Schaffer<o:p></o:p></i></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span style='color:black'> </span><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>Thanks Alfred<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span style='color:black'> </span><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'><o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'>Your Blind Vine Team<o:p></o:p></span></p><p class=MsoNormal style='margin-bottom:7.5pt;line-height:15.0pt;background:white'><span style='color:black'> </span><span lang=EN style='font-size:10.5pt;font-family:"Arial",sans-serif;color:#333333'><o:p></o:p></span></p><p class=MsoNormal><i><span style='color:black'>"A friend is someone who knows the song in your heart and can sing it back to you when you have forgotten the words." -Unknown<o:p></o:p></span></i></p><p class=MsoNormal><span style='color:black'> <o:p></o:p></span></p></div></div></div></div></body></html>